4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0001213900-26-070258
Options or other derivatives
- Director acquired 22,195 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Phillips Andrew John Director | 2026-06-17 | Grant or award · Option to Buy | +22,195 | 22,195 | D | ||
Loading xslF345X06/ownership.xml…